Henry A. Lardy
24Patents
10h-index
8Co-inventors
64Inventor score
Filing activity: Apr 10, 1992 → Mar 17, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6924274B2 | Use of Δ5-androstene-3β-ol-7,17-dione in the treatment of lupus erythematosus | Human Necessities | 58 | Expired |
| US5585371A | Treatment of immune system with .DELTA.5-androstenes | Human Necessities | 37 | Expired |
| US5296481A | Treatment process for promoting weight loss employing a substituted .DELTA. 5 | Human Necessities | 34 | Expired |
| US5292730A | Modulation of immune system with .DELTA.5-androstenes | Human Necessities | 33 | Expired |
| US5424463A | .DELTA.5-androstenes useful for promoting weight maintenance or weight loss and treatment process | Chemistry; Metallurgy | 29 | Expired |
| US5506223A | .DELTA.5-androstenes useful for promoting weight maintenance or weight loss and treatment process | Chemistry; Metallurgy | 20 | Expired |
| US5869709A | Process for effecting allylic oxidation | Chemistry; Metallurgy | 18 | Expired |
| US5641766A | UP-regulation of immune system with .DELTA. 5-Androstenes | Human Necessities | 15 | Expired |
| US7462610B2 | Prostate cancer treatment | Chemistry; Metallurgy | 13 | Active |
| US6384251B1 | Process for effecting allylic oxidation using dicarboxylic acid imides and chromium reagents | Chemistry; Metallurgy | 11 | Expired |
| US5707983A | Treatment of alzheimer's disease and modulation of immune system with .DELTA.5-androstenes | Human Necessities | 10 | Expired |
| US6111118A | Process for effecting allylic oxidation | Chemistry; Metallurgy | 9 | Expired |
| US7842680B2 | Diene and triene compounds and formulations | Chemistry; Metallurgy | 7 | Active |
| US6686486B1 | Process for effecting allylic oxidation | Chemistry; Metallurgy | 7 | Expired |
| US7514420B2 | Steroids having 1,8-unsaturation and formulations comprising same | Chemistry; Metallurgy | 7 | Active |
| US6153606A | Memory enhancement by the administration of .DELTA.5-androstene-3.beta.-ol-7,17-dione and 3.beta. esters thereof | Human Necessities | 7 | Expired |
| US6274746A | Process for allylic oxidation using metal hypochlorite and alkyl hydroperoxide | Chemistry; Metallurgy | 6 | Expired |
| US5807848A | Use of dehydroepeiandrosterone-3-carboxylates to control body weight | Human Necessities | 6 | Expired |
| US7550450B2 | Prostate cancer treatment | Chemistry; Metallurgy | 5 | Active |
| US5885977A | Use of .DELTA.5 androstenes in the treatment of HIV wasting syndrome | Human Necessities | 5 | Expired |
| US6489313B1 | Memory by the administration of &Dgr;5-androstene-3&bgr;-ol-7,17-dione and 3&bgr; esters | Human Necessities | 4 | Expired |
| US6372732B1 | Use of delta5-androstene-3beta-ol-7, 17-dione in the treatment of lupus erythematosus | Human Necessities | 3 | Expired |
| US6593316B2 | Use of &Dgr;5-androstene-3&bgr;ol-7,17-dione in the treatment of lupus erythematosus | Human Necessities | 1 | Expired |
| US7638509B2 | Diene compounds and formulations | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.